Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 10


Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.

Rappaport J, Volsky DJ.

J Neurovirol. 2015 Jun;21(3):235-41. doi: 10.1007/s13365-015-0346-y. Epub 2015 May 2. Review.


Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs.

Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, Miller M, Vella S, Schmitz JE, Ahlers J, Richman DD, Sekaly RP.

Lancet. 2013 Jun 15;381(9883):2109-17. doi: 10.1016/S0140-6736(13)60104-X. Epub 2013 Mar 29. Review.


Rapid down-regulation of γc on T cells in early SIV infection correlates with impairment of T-cell function.

Xu H, Wang X, Pahar B, Alvarez X, Rasmussen KK, Lackner AA, Veazey RS.

FASEB J. 2012 Jun;26(6):2294-305. doi: 10.1096/fj.11-195180. Epub 2012 Feb 28.


Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328).

Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu R.

AIDS Res Ther. 2010 Aug 5;7:30. doi: 10.1186/1742-6405-7-30.


Increased CD4+ T cell levels during IL-7 administration of antiretroviral therapy-treated simian immunodeficiency virus-positive macaques are not dependent on strong proliferative responses.

Leone A, Rohankhedkar M, Okoye A, Legasse A, Axthelm MK, Villinger F, Piatak M Jr, Lifson JD, Assouline B, Morre M, Picker LJ, Sodora DL.

J Immunol. 2010 Aug 1;185(3):1650-9. doi: 10.4049/jimmunol.0902626. Epub 2010 Jul 9.


Interleukin-2 therapy in patients with HIV infection.

INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D.

N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175.


Safety and efficacy of treatment using interleukin-2 in a patient with idiopathic CD4(+) lymphopenia and Mycobacterium avium-intracellulare.

Trojan T, Collins R, Khan DA.

Clin Exp Immunol. 2009 Jun;156(3):440-5. doi: 10.1111/j.1365-2249.2009.03910.x.


Functions of γC cytokines in immune homeostasis: current and potential clinical applications.

Overwijk WW, Schluns KS.

Clin Immunol. 2009 Aug;132(2):153-65. doi: 10.1016/j.clim.2009.03.512. Epub 2009 May 9. Review.


GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.

Stapleton JT, Chaloner K, Zhang J, Klinzman D, Souza IE, Xiang J, Landay A, Fahey J, Pollard R, Mitsuyasu R.

AIDS. 2009 Mar 13;23(5):605-10. doi: 10.1097/QAD.0b013e32831f1b00.


Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial.

Porter BO, Anthony KB, Shen J, Hahn B, Keh CE, Maldarelli F, Blackwelder WC, Lane HC, Kovacs JA, Davey RT, Sereti I.

AIDS. 2009 Jan 14;23(2):203-12. doi: 10.1097/QAD.0b013e32831cc114.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk